ライフサイエンスコーパス: agitation

1 0.002) with no differences in wakefulness or agitation.

2 nded in the surrounding fluid via controlled agitation.

3 ons had a significant impact specifically on agitation.

4 compared to common lift-off methods based on agitation.

5 hed and cultured in an incubator with gentle agitation.

6 ex relationship among wakefulness, pain, and agitation.

7 of the beads was measured individually after agitation.

8 re placed in liquid medium or buffer without agitation.

9 e performed simultaneously during the 10 min agitation.

10 adherent layer that can be removed by gentle agitation.

11 on events and critically depends on solution agitation.

12 ilation in order to reduce their anxiety and agitation.

13 ner in the presence of a constant mechanical agitation.

14 se food intake, and insufficient to decrease agitation.

15 f suicidal events, depression, or aggression/agitation.

16 reserved for short-term management of acute agitation.

17 t reduce agitation in patients with terminal agitation.

18 es called disruptive vocalisation, or verbal agitation.

19 awal syndrome, status epilepticus, and acute agitation.

20 ics of the active elements and their induced-agitation.

21 stresses: freeze-thaw cycling, heating, and agitation.

22 e anode in the waste solution and at 900 rpm agitation.

23 italized patients, a key feature of which is agitation.

24 n-agitation scale scores representing severe agitation (13% vs 25%) or moderate agitation (27% vs 22%

25 is of interventions targeting aggression and agitation (148 studies [21 686 patients]) showed that mu

26 leep changes (28% versus 7%, P = 0.003), and agitation (24% versus 6%, P = 0.008) were more common an

27 The most common neurological findings were agitation (25%), behavioral disorders (25%), muscle weak

28 ng severe agitation (13% vs 25%) or moderate agitation (27% vs 22%) within 24 hours of initiating stu

29 ied between ICUs: excessive sedation 12-38%; agitation 4-17%; poor relaxation 13-21%; poor ventilator

30 continued treatment owing to adverse events (agitation, 4; sedation, 1).

31 Such physiological agitation accelerated longitudinal mixing by more than a

32 dure was characterized by the application of agitation after extraction to break up the emulsion (tha

33 7), affective symptoms (hazard ratio=1.510), agitation/aggression (hazard ratio=1.942), mildly sympto

34 Psychosis (hazard ratio=2.007), agitation/aggression (hazard ratio=2.946), and any one c

35 line on the Neuropsychiatric Inventory (NPI) Agitation/Aggression domain (scale range, 0 [absence of

36 responders) showed significantly reduced NPI Agitation/Aggression scores for dextromethorphan-quinidi

37 In stage 2, NPI Agitation/Aggression scores were reduced from 5.8 to 3.8

38 In stage 1, mean NPI Agitation/Aggression scores were reduced from 7.1 to 3.8

39 e and agitation, in addition to efficacy for agitation/aggression, included reductions in the frequen

40 MARQUE intervention was not efficacious for agitation although feasible and cost-effective in terms

41 f 10:1 in an Eppendorf tube for 30 min under agitation and absence of light.

42 Agitation and addition of cellulases increased oil extra

43 n efficient approach to alleviating anxiety, agitation and adverse effects of sedative medication in

44 Agitation and aggression commonly arise in people with A

45 schizophrenia, are used to treat psychosis, agitation and aggression in Alzheimer's disease.

46 Pharmacological treatments for agitation and aggression in patients with Alzheimer's di

47 armacological approaches to the treatment of agitation and aggression in these patients.

48 agents have sufficient evidence in treating agitation and aggression to recommend use in routine cli

49 ions are most commonly prescribed to address agitation and aggression.

50 cts can present temporary behaviors of acute agitation and aggressiveness, named problem behaviors.

51 diffuse layer that can be easily removed by agitation and an inner layer that remains attached to th

52 the effect of nature-based sound therapy on agitation and anxiety on coronary artery bypass graft pa

53 compared with placebo significantly reduced agitation and caregiver distress; however, cognitive and

54 Scalable methods using mechanical agitation and chemical vapor deposition are adopted.

55 ctice Guidelines for the Management of Pain, Agitation and Delirium and from December 2010 to 2012, 3

56 idelines recommendations, based on the Pain, Agitation and Delirium guidelines.

57 the relationship between a hospital's pain, agitation and delirium order set quality, as assessed by

58 red inappropriate because of the severity of agitation and delirium.

59 ion and fibril formation, promoted by manual agitation and elevated temperatures.

60 ials were carried out at 25 degrees C, under agitation and for five time periods (0, 6, 12, 24 and 48

61 mixed ADNC/LATE-NC may be protective against agitation and frontal symptoms in dementia caused by Alz

62 from citalopram, and those with more severe agitation and greater cognitive impairment were at great

63 randomised care homes (1:1) to the Managing Agitation and Raising Quality of Life (MARQUE) intervent

64 get range of sedation-scores on the Richmond Agitation and Sedation Scale (which is scored from -5 [u

65 fined as a score of -2 to -3 on the Richmond Agitation and Sedation Scale [RASS], on which scores ran

66 cting ICU delirium in patients with Richmond Agitation and Sedation Scale Score greater than -3.

67 n Assessment Method for the ICU and Richmond Agitation and Sedation Scale.

68 th expertise in guideline development, pain, agitation and sedation, delirium management, and associa

69 arch engines, related to pain and analgesia, agitation and sedation, delirium, and related clinical o

70 of this circuit abnormality are psychomotor agitation and stereotypical behaviors, which are relieve

71 emonstrated clinically relevant efficacy for agitation and was generally well tolerated.

72 echanisms underlying the sevoflurane-induced agitation and will promote future studies to further det

73 Those with moderate agitation and with lower levels of cognitive impairment

74 95% for NaCl and 4.35% for KCl in brine with agitation and, the main diffusion coefficients 2.692 x 1

75 of sedative exposure (wakefulness, pain, and agitation), and occurrence of iatrogenic withdrawal.

76 synchronization, unnecessary deep sedation, agitation, and an overall optimum sedation metric.

77 evere cognitive impairment, have more severe agitation, and be treated with lorazepam.

78 he least cognitive impairment, have moderate agitation, and be within the middle age range (76-82 yea

79 The guidelines included an ICU pain, agitation, and delirium care bundle designed to facilita

80 This article describes: 1) the ICU pain, agitation, and delirium care bundle in more detail, link

81 Implementation of the ICU pain, agitation, and delirium care bundle is expected to have

82 Widespread implementation of the ICU pain, agitation, and delirium care bundle is likely to result

83 The ICU pain, agitation, and delirium care bundle provides a framework

84 An ICU pain, agitation, and delirium care bundle was created to facil

85 e of Critical Care Medicine's 2013 ICU Pain, Agitation, and Delirium Clinical Practice Guidelines.

86 The pain, agitation, and delirium database includes over 19,000 re

87 f Critical Care Medicine has developed pain, agitation, and delirium guidelines and promoted mobility

88 The pain, agitation, and delirium guidelines include 54 evidence-b

89 The 2013 ICU pain, agitation, and delirium guidelines provide critical care

90 um-oriented measures based on the 2013 Pain, Agitation, and Delirium guidelines showed improved healt

91 Implementation of the pain, agitation, and delirium guidelines taking into account c

92 o facilitate the implementation of the pain, agitation, and delirium guidelines using the evidence-ba

93 will explore relationships between the pain, agitation, and delirium guidelines, mobility recommendat

94 imize implementation of the recent ICU pain, agitation, and delirium guidelines, which has many simil

95 nt (ABCDEF) bundle in implementing the Pain, Agitation, and Delirium guidelines.

96 ed to facilitate implementation of the pain, agitation, and delirium guidelines.

97 for facilitating implementation of the pain, agitation, and delirium guidelines.

98 created to facilitate adoption of the pain, agitation, and delirium guidelines.

99 ine published a revised version of the pain, agitation, and delirium guidelines.

100 ional team model to operationalize the Pain, Agitation, and Delirium guidelines.

101 ated and interdisciplinary fashion; 2) pain, agitation, and delirium implementation strategies; and 3

102 ctice guidelines for the management of pain, agitation, and delirium in adult patients in the ICU sug

103 The management of pain, agitation, and delirium in critically ill patients can b

104 protocols for preventing and treating pain, agitation, and delirium in critically ill patients.

105 undle in more detail, linking pain, sedation/agitation, and delirium management in an integrated and

106 ential synergistic benefits of linking pain, agitation, and delirium management strategies to other e

107 Linking the ICU pain, agitation, and delirium management strategies with spont

108 critically ill patients, and it links pain, agitation, and delirium management to spontaneous awaken

109 to new guidelines for the treatment of pain, agitation, and delirium may be the best pathway toward r

110 ctice guidelines for the management of pain, agitation, and delirium recommend either daily sedation

111 al signs, depression, psychosis, aggression, agitation, and dementia medication use.

112 person-centered care, on antipsychotic use, agitation, and depression in people with dementia living

113 ary outcome measures were antipsychotic use, agitation, and depression.

114 Psychomotor signs range from stupor to agitation, and include pathognomonic features such as ve

115 e most common AEs in F17464 group: insomnia, agitation, and increased triglycerides; worsening of sch

116 ep time, higher levels of anxiety, increased agitation, and more feelings of disembodiment and amnesi

117 houghts and behavior, depression, aggression/agitation, and nausea and to compare effects in patients

118 cific surface, the H2O content of K2CO3, and agitation, and these dependences can be rationalized bas

119 units (ICUs) requires the avoidance of pain, agitation, and unnecessary deep sedation, but these outc

120 Delusion, hallucination, agitation, anxiety, apathy, motor-disturbances, night-ti

121 fluential factor for MF release, rather than agitation as previously thought.

122 is work, for the first time, fully automated agitation-assisted demulsification (AAD)-DLLME integrate

123 ys onset of fibrillation (lag time on gentle agitation at 37 degrees C was prolonged by 4-fold), (iii

124 lted in a significantly greater reduction in agitation at 8 hours.

125 Patient agitation at the outset of interaction was associated wi

126 ounds and antioxidant activity by mechanical agitation (at 130 rpm) and ultrasound assistance (at 182

127 benign tumour, were cultured for 30 days in agitation-based culture systems with 100% success rate.

128 el, demonstrate a straightforward mechanical agitation-based methodology for controlling this variant

129 omains included pain/discomfort and sedation-agitation behaviors; sedative, analgesic, and neuromuscu

130 ents: antipsychotics for severe psychosis or agitation; benzodiazepines, particularly in the late sta

131 We hypothesized that mechanical agitations can accelerate longitudinal mixing of Corti f

132 le Alzheimer disease, clinically significant agitation (Clinical Global Impressions-Severity agitatio

133 Symptoms included agitation, confusion, myoclonus, tremor, and seizures (1

134 The Dexmedetomidine to Lessen ICU Agitation (DahLIA) study was a double-blind, placebo-con

135 an College of Critical Care Medicine's Pain, Agitation, Delirium Management Guidelines' literature da

136 r Center (Houston, TX, USA), with refractory agitation, despite low-dose haloperidol, were randomly a

137 n in scores on delusions, hallucinations and agitation domains of the Neuropsychiatric Inventory) and

138 s to be useful as a rescue drug for treating agitation due to delirium in nonintubated patients in wh

139 ol (2 mg) intravenously upon the onset of an agitation episode.

140 static etching and high-frequency ultrasonic agitation etching was devoted in our case.

141 In addition, NaCl and agitation facilitated the creation of giant hybrid vesic

142 h lower total Neuropsychiatric Inventory and agitation factor scores than pure ADNC, and lower fronta

143 fect the extraction kinetics, such as sample agitation, fiber coating thickness, and presence of a bi

144 ure was induced at 42.5 degrees C under mild agitation for 42h.

145 UV exposure, chemical initiator, or thermal agitation for crosslinking and thus provides a nontoxic

146 Alzheimer disease and clinically significant agitation from 8 academic centers in the United States a

147 of participants experiencing a reduction in agitation from baseline to post intervention, there rema

148 of participants experiencing a reduction in agitation from the pre-intervention to during interventi

149 meshes was tested by performing rapid vortex agitation (>/=3200 rpm) in LC/MS-grade solvents and by e

150 Agitation (hazard ratio=3.06, 95% CI=1.89-4.93), apathy

151 ing, especially with simultaneous mechanical agitation; however, washing in the presence of hypochlor

152 ts included transient symptoms of hypomania, agitation, impulsivity, and sleeping disorders.

153 es are shown to be stable over time and with agitation in a centrifuge.

154 ic interventions for reducing aggression and agitation in adults with dementia.

155 response to citalopram in the Citalopram for Agitation in Alzheimer Disease (CitAD) study to identify

156 The Citalopram for Agitation in Alzheimer Disease Study (CitAD) was a rando

157 ned secondary analysis of the Citalopram for Agitation in Alzheimer's Disease study, the authors eval

158 Addressing agitation in care homes might require resourcing for del

159 The use of benzodiazepines to control agitation in delirium in the last days of life is contro

160 steritic olivine was subjected to rotational agitation in different seawater media for periods of day

161 fuse into giant (>1 mum) vesicles with mild agitation in dilute aqueous NaCl solutions.

162 s to evaluate the efficacy of citalopram for agitation in patients with Alzheimer disease.

163 Citalopram has been shown to improve agitation in patients with Alzheimer's disease.

164 f three neuroleptic strategies on refractory agitation in patients with cancer with terminal delirium

165 as an adjuvant to haloperidol for persistent agitation in patients with delirium in the setting of ad

166 hree strategies of neuroleptics might reduce agitation in patients with terminal agitation.

167 urane, a commonly used anesthetic, may cause agitation in patients.

168 ve nonpharmacological intervention to reduce agitation in persons with dementia in nursing homes.

169 armacological intervention that may decrease agitation in selected hospitalized delirious patients.

170 modynamic responses arising from anxiety and agitation in weaning from mechanical ventilation in coro

171 cts in patients with Alzheimer's disease and agitation, in addition to efficacy for agitation/aggress

172 steric resistance between vesicles and, with agitation, increasing the probability of contact between

173 Continued agitation initiates a sequence of instabilities of this

174 thermal fluctuations alone; a large thermal agitation inside the crystal lattice can trigger the irr

175 ted thoughts, hopelessness, restlessness and agitation, insomnia and impulsiveness as measured by the

176 ere based on scores from the Cohen-Mansfield Agitation Inventory (CMAI) and the Neuropsychiatric Inve

177 8 months, measured using the Cohen-Mansfield Agitation Inventory (CMAI).

178 s to extinguish or reduce patient aggression/agitation irrespective of its cause, and improve staff-p

179 Agitation is common among patients with Alzheimer diseas

180 Agitation is common, persistent, and associated with adv

181 ks) although the impact on other symptoms of agitation is limited.

182 e through pre-recorded video messages on the agitation level of hospitalized, delirious, acutely agit

183 on group had significantly lower anxiety and agitation levels than the control group.

184 gn studied the influence of four parameters, agitation, liquid/solid (L/S) ratio, and cellulase and p

185 e but was associated with decreased risk for agitation (low SOE).

186 ly monitor multiple aspects of pain-sedation-agitation management within ICUs.

187 QT prolongation, use of this agent to treat agitation may be limited to a subgroup of people with de

188 0%-46%] of days; P < .001) and any report of agitation (median, 60% [IQR, 33%-80%] vs 40% [IQR, 13%-6

189 Without agitation, mutant cells aggregate and settle out of the

190 by central nervous system hyperexcitability (agitation, myoclonus, tremor, seizures), pleocytosis, an

191 roving transport is generally limited to the agitation of reagents, a mode of flow generation inheren

192 ysis were accomplished using magnetic-driven agitation of silica beads.

193 hout any pretreatment rather than the smooth agitation of the samples with a magnetic stirrer in orde

194 enzyme concentrations, pH, temperature, and agitation on product formation.

195 nts with Alzheimer's disease and symptoms of agitation or psychosis were treated with risperidone for

196 nts with Alzheimer's disease and symptoms of agitation or psychosis were treated with risperidone for

197 Unlike mechanical agitation or robotic selection, orienting using MagLev i

198 also found between the anxiety (p<0.002) and agitation (p<0.001) scores in two groups.

199 zheimer's disease and clinically significant agitation, participants were randomly assigned to receiv

200 herapeutic including varied pH, temperature, agitation, photo, and chemical stresses.

201 fined as being free from excessive sedation, agitation, poor limb relaxation, and poor ventilator syn

202 avior Scale was used to measure the level of agitation prior to, during, immediately following, and 3

203 ex pharmaceutical problem: development of an agitation protocol in an agitated filter dryer to ensure

204 The temperature and agitation rate were critical for kefiran production duri

205 The influence of fermentation temperature, agitation rate, and additions of carbon sources, nitroge

206 the formaldehyde concentration, temperature, agitation rate, and surfactant on HLC and KOL were inves

207 ed percentage of surfactant used, sample pH, agitation rate, extraction duration, salting out effect,

208 In a simple one-pot agitation reaction, 25 dimers are constructed in paralle

209 d HF etching with multi-frequency ultrasonic agitation, respectively.

210 hours per study day spent agitated (Sedation Agitation Scale >/= 5) (p = 0.008), but it did not influ

211 patients spent alive without coma (Sedation Agitation Scale </= 2) or delirium (p = 0.36), the time

212 ation-Sedation Scale (19.5) and the Sedation-Agitation Scale (19).

213 nd Agitation-Sedation Scale and the Sedation-Agitation Scale are the most valid and reliable subjecti

214 ation-Sedation Scale of -3 to -5 or Sedation-Agitation Scale of 2 or 1.

215 omains correlated with the Richmond Sedation Agitation Scale score (Spearman rho = 0.75) and were rel

216 tute Withdrawal Assessment or Riker sedation-agitation scale scores representing severe agitation (13

217 ies of 6 behavioral pain scales, 10 sedation/agitation scales, and 5 delirium monitoring tools.

218 tation (Clinical Global Impressions-Severity agitation score >/=4), and a Mini-Mental State Examinati

219 The primary outcome was agitation score at 8 months, measured using the Cohen-Ma

220 y video group had significantly lower median agitation scores during the intervention period (p<0.001

221 The median agitation scores for the three groups were not significa

222 ups displayed a significant change in median agitation scores over the four time periods (p<0.001), w

223 1) was done, stratified by baseline Richmond Agitation Sedation Scale (RASS) scores.

224 ; p = 0.005, 0.011, 0.036) and more Richmond Agitation Sedation Scale assessments between (-2 and 1),

225 Confusion Assessment Method-ICU and Richmond Agitation Sedation Scale daily during hospitalization.

226 with the MIRUS system targeted to a Richmond Agitation Sedation Scale from -3 to -5 by adaptation of

227 ssment Method-ICU and corresponding Richmond Agitation Sedation Scale score greater than 0.

228 ssment Method-ICU and corresponding Richmond Agitation Sedation Scale score less than or equal to 0 a

229 lemented, which recommends a target Richmond Agitation Sedation Scale score of 0 (alert and calm) and

230 ther, wakefulness increased (median Richmond Agitation Sedation Scale score per patient: -1.5 vs. -4.

231 for developing our method, we used Richmond Agitation Sedation Scale scores grouped into four levels

232 , there was an increase in the mean Richmond Agitation Sedation Scale scores on weekdays of 0.88 (p <

233 0.0001) and an increase in the mean Richmond Agitation Sedation Scale scores on weekends of 1.21 (p <

234 dol until agitation was controlled (Richmond Agitation Sedation Scale scoring range, 0 to -2) or reac

235 Median Richmond Agitation Sedation Scale was -4.5 (interquartile range,

236 Data collected included Richmond Agitation Sedation Scale, minimum alveolar concentration

237 d using the Faces Anxiety Scale and Richmond Agitation Sedation Scale, respectively.

238 gorithm targeted to light sedation (Richmond Agitation Sedation Score of -2 to 1).

239 four levels, denoted "unarousable" (Richmond Agitation- Sedation Scale = -5, -4), "sedated" (-3, -2,

240 The Sedation Quality Assessment Tool agitation-sedation domains correlated with the Richmond

241 n Scale < 0) and nonsedated states (Richmond Agitation-Sedation Scale > 0).

242 e (accuracy = 79%) between sedated (Richmond Agitation-Sedation Scale < 0) and nonsedated states (Ric

243 published psychometric properties: Richmond Agitation-Sedation Scale (19.5) and the Sedation-Agitati

244 The primary outcome was change in Richmond Agitation-Sedation Scale (RASS) score (range, -5 [unarou

245 was monitored twice daily using the Richmond Agitation-Sedation Scale and continuously monitored by p

246 ed psychometric scoring system, the Richmond Agitation-Sedation Scale and the Sedation-Agitation Scal

247 correlation coefficient, 0.83; and Richmond Agitation-Sedation Scale intraclass correlation coeffici

248 n Assessment Method for the ICU and Richmond Agitation-Sedation Scale items.

249 Deep sedation was defined as Richmond Agitation-Sedation Scale of -3 to -5 or Sedation-Agitati

250 A Richmond Agitation-Sedation Scale score between -3 and -4 was mai

251 Richmond Agitation-Sedation Scale scores were acquired prospectiv

252 Richmond Agitation-Sedation Scale scores were grouped into four l

253 onfusion Assessment Method-ICU with Richmond Agitation-Sedation Scale to assess sedation was the most

254 Richmond Agitation-Sedation Scale was -4 (-4 to -3) before, -4 (-

255 sion Assessment Method for the ICU, Richmond Agitation-Sedation Scale, and Delirium Rating Scale-Revi

256 sessment Method for the ICU and the Richmond Agitation-Sedation Scale.

257 was coma-free days assessed by the Richmond Agitation-Sedation Scale.

258 n Assessment Method for the ICU and Richmond Agitation-Sedation Scale.

259 um-/coma-free days assessed through Richmond Agitation-Sedation Scale/Confusion Assessment Method for

260 etric analyses to evaluate and compare pain, agitation/sedation, and delirium assessment tools.

261 to assessing, treating, and preventing pain, agitation/sedation, and delirium in critically ill patie

262 interdisciplinary approach to managing pain, agitation/sedation, and delirium.

263 of 37, 41%), confusion (12 of 37, 32%), and agitation (seven of 37, 19%).

264 Temperature, pH, agitation speed and release media composition were obser

265 Agitation speed and surfactant to dodecanol weight ratio

266 found at pH=12, temperature of 45 degrees C, agitation speed of 800rpm and agitation time of 15min, u

267 SPE process, experimental parameters such as agitation speed, temperature, time, and pH were optimize

268 aspect ratio was observed on increasing the agitation speed.

269 inations of temperature, pH, oxygen flux, or agitation speed.

270 biosensor in different temperatures, pH and agitation speeds was also analyzed.

271 ture the released DNA in a single mechanical agitation step, and we show that bound DNA can be amplif

272 om the 18-point Neurobehavioral Rating Scale agitation subscale (NBRS-A) and the modified Alzheimer D

273 caregiver distress scores but not on the NPI agitation subscale, ADLs, or in less use of rescue loraz

274 icated for the treatment of irritability and agitation symptoms in children with autism spectrum diso

275 ng in care homes have distressing and costly agitation symptoms.

276 l understanding of transport in conventional agitation systems and in microfluidics, the latter under

277 s are achieved in aqueous and in interfacial agitation systems.

278 year of vintage and fermentation procedures (agitation, temperature).

279 d to investigate the effect of water-volume, agitation, temperature, and duration of the wash on MF r

280 sedating medications for treatment of severe agitation that poses risk to patient or staff safety or

281 sychiatric symptoms, including psychosis and agitation, that was linked to increased risk of institut

282 In physiological conditions and under agitation the residue 49-127 proteolytic fragment rapidl

283 On gentle agitation, the SCI retained full activity for >140 days

284 At the same time, during agitation, there was sufficient space for collisions wit

285 to investigate the influence of the factors agitation time (2 and 4 h) and the percentage of KOH (60

286 DDTC, and Triton X-100 concentration, vortex agitation time and complexation time) were optimized in

287 45 degrees C, agitation speed of 800rpm and agitation time of 15min, ultrasound treatment time of 70

288 sing a 60% (w/v) solution of KOH and with an agitation time of 2 h.

289 The factors % KOH and agitation time were significant, and an increase in thei

290 olution at elevated temperature, followed by agitation to induce emulsification.

291 o optimize the main experimental parameters (agitation, voltage, and time) with standard solutions in

292 ity for forming aggregates when subjected to agitation (vortexing) stress.

293 received IV bolus doses of haloperidol until agitation was controlled (Richmond Agitation Sedation Sc

294 on mushrooms in static brine and brine under agitation was modeled based on the generalization of Fic

295 er HF etching with high-frequency ultrasonic agitation were also investigated in this study.

296 Haemodynamic variables, anxiety levels and agitation were assessed using the Faces Anxiety Scale an

297 over 100 h at 37 degrees C under continuous agitation, whereas commercial formulations of insulin an

298 patients with probable Alzheimer disease and agitation who were receiving psychosocial intervention,

299 ormation methods include biolistic delivery, agitation with glass beads, and electroporation.

300 ere subjected to 48 hours of interruption of agitation with or without MAPK inhibitors.